Silverlake Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Silverlake Wealth Management's LLY Position: Q2 2026 in Review
Silverlake Wealth Management reduced its Eli Lilly (LLY) stake by 3.7% in Q2 2026, selling an estimated $69.5K and leaving 1,793 shares worth $2.15M. The position accounts for 0.41% of the portfolio, ranked #72.
Silverlake Wealth Management first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.19M in Q4 2025. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Silverlake Wealth Management held 1,793 shares of Eli Lilly worth $2.15M as of Q2 2026.
- Silverlake Wealth Management sold 68 Eli Lilly shares in Q2 2026, an estimated $69.5K.
- Eli Lilly made up 0.41% of Silverlake Wealth Management's portfolio in Q2 2026, its #72 holding.
- Silverlake Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- Silverlake Wealth Management's Eli Lilly position peaked at $2.19M in Q4 2025.
- 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Silverlake Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.